BeStock  
Stocks › Biotechnology › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2736Biotechnology
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$30.15M+49.1% YoY
Net profit-$26.50M+55.2% YoY
Diluted EPS-$0.51+63.1% YoY
Free cash flow-$24.37M+27.2% YoY
Operating cash flow-$24.37M

Revenue, last 7 quarters

$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 7 quarters

$-99.0KMar '25$-381.0KJun '25$-59.1MSep '25$-6.5MDec '25$-14.3MMar '26$-15.0MJun '26$-26.5MSep '26

Diluted EPS by quarter

0.00Mar '25-0.01Jun '25-1.38Sep '25-0.10Dec '25-0.33Mar '26-0.30Jun '26-0.51Sep '26

Free cash flow by quarter

$0.0Mar '25$0.0Jun '25$-33.5MSep '25$-2.1MDec '25$-8.2MMar '26$-16.9MJun '26$-24.4MSep '26

Profitability & balance sheet

Return on equity-13.2%
Return on assets-12.8%
Return on invested capital-14.4%
Current ratio21.57
Liabilities / assets3.3%
Cash & investments$349.27M
Total debt$100,000.00
Net cash (debt)$349.17M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Net Non-Operating Interest Income (Expense) $3.71M $889,000.00 $771,000.00 $696,000.00 $527,000.00
Operating Expense $30.15M $15.88M $15.05M $66.75M $6.98M
Selling and Admin Expenses $12.61M $4.76M $4.14M $3.02M $2.48M
-General & Admin Expense $12.61M $4.76M $4.14M $3.02M $2.48M
Research & Development $17.54M $11.13M $10.91M $63.73M $4.50M
Operating Profit -$30.15M -$15.88M -$15.05M -$66.75M -$6.98M
Net Profit -$26.50M -$14.99M -$14.28M -$66.05M -$6.45M
Non-Operating Interest Income $3.71M $889,000.00 $771,000.00 $696,000.00 $527,000.00
Other Income (Expense) -$58,000.00 $5,000.00 -$2,000.00 $1,000.00 –
Other Non-Operating Income (Expenses) -$58,000.00 $5,000.00 -$2,000.00 $1,000.00 –
Pretax Profit -$26.50M -$14.99M -$14.28M -$66.05M -$6.45M
Profit from Continuing Operations -$26.50M -$14.99M -$14.28M -$66.05M -$6.45M
Net Income to Parent Company -$26.50M -$14.99M -$14.28M -$66.05M -$6.45M
Net Income to Common Stockholders -$26.50M -$18.60M -$14.28M -$66.05M -$6.45M
Basic EPS -$0.51 -$0.30 -$0.33 -$5.32 -$0.10
Diluted EPS -$0.51 -$0.30 -$0.33 -$5.32 -$0.10
Preferred Stock Dividends – $3.62M – – –
Special Income (Charges) – $0.00 $0.00 -$62.24M –
-Less:Other Special Charges – – – $62.24M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $514.45M $126.96M $81.88M $89.35M $89.35M
Total Current Assets $359.57M $123.45M $81.07M $89.28M $89.28M
Cash and Cash Equivalents & Short-Term Investments $349.27M $122.83M $80.58M $89.16M $89.16M
-Cash and Cash Equivalents $121.29M $122.83M $80.58M $89.16M $89.16M
-Short Term Investments $227.98M – – – –
Other Current Assets $10.30M $614,000.00 $496,000.00 $119,000.00 $119,000.00
Total Non-Current Assets $154.88M $3.51M $806,000.00 $70,000.00 $70,000.00
Net PPE $530,000.00 $630,000.00 $736,000.00 – –
Additional Paid-In Capital $620.71M $0.00 $1.94M $179,000.00 $179,000.00
-Preferred Stock $0.00 $213.52M $149.89M $149.89M $149.89M
Retained Earnings -$122.40M -$95.91M -$80.33M -$66.05M -$66.05M
Gains/Losses Not Affecting Retained Earnings -$718,000.00 – – – –
Other Non-Current Liabilities $75,000.00 $86,000.00 $89,000.00 $91,000.00 $91,000.00
-Long Term Capital Lease Obligation $100,000.00 $198,000.00 $294,000.00 – –
Long Term Debt and Capital Lease Obligation $100,000.00 $198,000.00 $294,000.00 – –
Total Non-Current Liabilities $175,000.00 $284,000.00 $383,000.00 $91,000.00 $91,000.00
-Current Capital Lease Obligation $415,000.00 $377,000.00 $373,000.00 – –
Current Accrued Expenses $5.52M $4.47M $1.19M $3.87M $3.87M
-Accounts Payable $1.98M $2.67M $7.74M $1.06M $1.06M
Total Equity $497.60M $117.61M $71.49M $84.02M $84.02M
Stockholders' Equity $497.60M $117.61M $71.49M $84.02M $84.02M
Capital Stock $8,000.00 $213.52M $149.89M $149.89M $149.89M
-Common Stock $8,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
Short-Term Debt and Capital Lease Obligation $415,000.00 $377,000.00 $373,000.00 – –
Total Liabilities $16.85M $9.34M $10.39M $5.33M $5.33M
Payables $1.98M $2.67M $7.74M $1.06M $1.06M
-Gross PPE $530,000.00 $630,000.00 $736,000.00 – –
Other Non-Current Assets $98,000.00 $70,000.00 $70,000.00 $70,000.00 $70,000.00
Total Current Liabilities $16.67M $9.06M $10.00M $5.24M $5.24M
-Available for Sale Securities $154.25M – – – –
Investments and Advances $154.25M – – – –
Convertible preferred securities – $213.52M $149.89M $149.89M –
Non-Current Deferred Assets – $2.81M – – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$24.37M -$16.95M -$5.19M -$2.01M -$1.27M
Net cash flow from continuing operations -$24.37M -$16.95M -$5.19M -$2.01M -$1.27M
Net Income from Continuing Operations -$26.50M -$14.99M -$14.28M -$66.05M -$6.45M
Depreciation & Depletion & Amortization $3,000.00 $3,000.00 $2,000.00 – –
Change in Working Capital -$6.32M -$3.05M $7.33M $1.62M $1.98M
-Change in Prepaid Assets -$9.69M -$120,000.00 -$342,000.00 -$119,000.00 -$108,000.00
-Change in Payables and Accrued Expense $3.33M -$2.93M $7.78M $1.81M $2.16M
-Change In Other Working Capital $70,000.00 $0.00 -$105,000.00 – –
Net cash flow from investing -$382.45M $8,000.00 -$3.04M -$33.57M -$835,000.00
Net Common Stock Issuance $0.00 – – $95,000.00 $89,000.00
Ending Cash Balance $121.29M $122.83M $80.58M $89.16M $89.16M
Net Other Financing Charges -$3.79M -$399,000.00 -$363,000.00 – –
Net Preferred Stock Issuance -$15,000.00 – – $124.65M $23.65M
Net Cash Flow from Continuing Financing Activities $405.28M $59.20M -$363,000.00 $124.74M $23.74M
Financing Cash Flow $405.28M $59.20M -$363,000.00 $124.74M $23.74M
Net Intangibles Purchase and Sale $0.00 $0.00 -$3.00M -$33.57M -$835,000.00
Beginning Cash Balance $122.83M $80.58M $89.16M $0.00 $67.53M
Net PPE Purchase and Sale $0.00 $8,000.00 -$36,000.00 – –
Free Cash Flow -$24.37M -$16.94M -$8.22M -$35.58M -$2.11M
Net Cash Flow from Continuing Investing Activities -$382.45M $8,000.00 -$3.04M -$33.57M -$835,000.00
Net Change in Cash -$1.54M $42.26M -$8.59M $89.16M $21.63M
-Change in Other Current Assets – – – -$70,000.00 -$70,000.00
Other Non-Cash Items – – – $62.24M $3.03M

Discussion

No comments yet — be the first to weigh in on BRVE.

Sign in to join the discussion.

Scroll to Top